Financial statements Pharma2Pharma

Balance sheet of Pharma2Pharma

Company age:
Age:
18 y. 7 m. 29 d.
Share capital:
Share capital:
100 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of PHARMA2PHARMA

Year
2018
2019
2020
2021
2022
2023
Total assets 1 720 161,94 1 774 798,35 1 426 062,08 1 692 605,43 1 588 179,82 1 699 102,10
A. Fixed assets 174 089,00 144 809,39 119 418,81 219 950,71 322 181,12 366 345,96
B. Current assets 1 546 072,94 1 629 988,96 1 306 643,27 1 472 654,72 1 265 998,70 1 332 756,14
C. Share capital contributions (basic funds) 0,00 0,00 0,00 - - -
D. Own shares (stocks) 0,00 0,00 0,00 - - -
Total liabilities 1 720 161,94 1 774 798,35 1 426 062,08 1 692 605,43 1 588 179,82 1 699 102,10
A. Equity 1 181 644,62 1 193 775,44 1 086 593,69 1 261 353,97 1 234 180,75 1 126 835,57
B. Liabilities and provisions for liabilities 538 517,32 581 022,91 339 468,39 431 251,46 353 999,07 572 266,53
I. Long-term liabilities 122 303,09 45 000,00 0,00 253 239,51 53 957,62 272 494,36
II. Short-term liabilities 414 194,89 482 674,77 203 136,54 176 547,07 295 059,14 288 870,02
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.